Pelvic Inflammatory Disease (PID) News and Research

RSS
New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

New survey highlights need for BV awareness and education to ensure proper care

New survey highlights need for BV awareness and education to ensure proper care

CDC warns about steep rise in STDs among Americans

CDC warns about steep rise in STDs among Americans

Study finds low screening rates for adolescents with PID in nation’s ED setting

Study finds low screening rates for adolescents with PID in nation’s ED setting

STDs are becoming more difficult to treat due to antibiotic resistance, warns WHO

STDs are becoming more difficult to treat due to antibiotic resistance, warns WHO

Researchers develop first protective vaccine against insidious STI

Researchers develop first protective vaccine against insidious STI

Gonorrhoea infections increase across Europe

Gonorrhoea infections increase across Europe

New way of growing fallopian tube cells in culture may boost understanding of female genital diseases

New way of growing fallopian tube cells in culture may boost understanding of female genital diseases

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

Information about female condom is necessary to communicate with young people

Information about female condom is necessary to communicate with young people

Novel proteins may lead to new ways to combat venereal disease

Novel proteins may lead to new ways to combat venereal disease

Guerbet: FDA approves manufacturing plant for Lipiodol (ethiodized oil) Injection

Guerbet: FDA approves manufacturing plant for Lipiodol (ethiodized oil) Injection

New assay allows rapid and sensitive detection of Chlamydia trachomatis

New assay allows rapid and sensitive detection of Chlamydia trachomatis

New gonorrhea treatment eliminates gonococcal infection from female mice

New gonorrhea treatment eliminates gonococcal infection from female mice